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See Article, pages 732–740Sleep disturbance with reversal of the day and night cycle is a
well known phenomenon in patients with hepatic encephalopa-
thy irrespective of etiology as shown in animal models and in
humans [1–3]. Furthermore, insomnia, fatigue, depression, and
cognitive impairment are common symptoms in patients with
chronic liver disease (CLD) with cirrhosis. During the past
15 years, several studies have been published on the impact of
cirrhosis such as primary biliary cirrhosis, non-alcoholic fatty
liver disease, and Wilson’s disease on the quality of sleep [4–6].
However, it is less known that abnormal sleep patterns have also
been documented in up to 50% of patients with cirrhosis in the
absence of overt hepatic encephalopathy or even in patients with
CLD without cirrhosis [5]. It is sometimes difﬁcult to differentiate
between an organic cause of fatigue and insomnia from psychiat-
ric disorders of variable severity in CLD in general and in chronic
hepatitis C patients in particular [7]. Sleep patterns are dictated
by 24 h circadian clocks, subjected to light and darkness cycles,
which control numerous metabolic activities such as body tem-
perature, blood pressure, melatonin, cortisol and growth hor-
mone levels, urine output as well as mood and cognitive
abilities. Such endogenous circadian cycles exist not only in
humans but also in animals, plants, algae, bacteria, and fungi
[8]. Disruption of clock genes, which control the circadian
rhythms, have recently been linked to sleep disorders and have
an impact on metabolic activities [9,10]. Sleep and circadian
rhythm disruption may have serious consequences on emotional,
cognitive, and somatic responses. For example, inadequate sleep
may lead to exhaustion, increased irritability, mood ﬂuctuation
such as depression, anxiety or anger, reduced concentration,
attention deﬁcit disorder, decreased memory, decreased produc-
tivity and creativity, drowsiness, unintended sleep, weight gain,
metabolic abnormalities such as hyperglycemia, and more [11].
(The interested reader is referred to a recent review entitled
‘‘Sleep Disorders in Chronic Liver Disease’’ [3].)Journal of Hepatology 20
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Open access under CC BY-NC-ND license.In the past two decades, referral of patients with chronic hep-
atitis C (CHC) is dominating the practice of clinical hepatologist
worldwide, yet sleep disturbances in CHC patients without cir-
rhosis have received relatively little attention [3,12,13]. In the
present issue of the journal, Dr. Heeren and co-workers from
the Hannover Medical School in Germany report their observa-
tions on altered sleep quality in a cohort of CHC patients without
overt cirrhosis or classical hepatic encephalopathy [14]. The
study cohort (N = 20, mean age 56.8 yr) was recruited from a
small subgroup (N = 143) of the original HCV infected 1833
women who received an HCV contaminated anti-D immunoglob-
ulin over three decades ago [15]. Thus twenty anti-HCV positive,
genotype 1b patients of whom 12 were still HCV-RNA positive by
PCR participated in the study. The control population consisted of
19 age matched healthy females (mean age 55.3 yr). The unique
characteristic relevant to the goals of the discussed study is the
relatively benign course of CHC without cirrhosis over a period
of more than thirty years in this selected group of women who
nevertheless complained among other symptoms of weakness,
fatigue, and decreased exertional capacity.
The methodology used to assess the various study variables is
broad and quite complex. Participants were asked to ﬁll a number
of questionnaires including the Pittsburgh Sleep Quality Index
measuring sleep quality; the Epworth Sleepiness Scale measuring
daytime sleepiness; the Fatigue Impact Scale measuring the
impact of fatigue on daily activity; the Back Depression Inventory
measuring depression; the Hospital Anxiety and Depression Scale
measuring emotional alteration and the SF-36 questionnaire
measuring health related quality of life. Furthermore, patients
had to ﬁll a sleep diary and use an actigraph which is a wrist
worn device for monitoring of motor activity over a period of
24 h/day for 5 days. Obtained scores from the various question-
naires ﬁlled by the study and control groups as well as actigraphy
scores were compared and a Spearman correlation test was used
to evaluate a relationship between fatigue, quality of life, sleep
parameters, and actigraphy results.
The major ﬁndings of this study indicate that in contrast to
healthy controls, patients with a history of chronic hepatitis C
virus infection without overt cirrhosis may develop a disrupted
circadian rhythm. This so called circadian arrhythmia is associ-
ated with an altered sleep pattern, insomnia, fatigue, depression,
and reduced quality of life, which correlate with one another.14 vol. 60 j 685–686
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Although patients displayed an increased nocturnal activity, no
correlation could be established between fatigue and sleep pat-
tern abnormality and 24 h activity level.
Comments: The reported results suggest and conﬁrm previous
observations that sleep disruption and its consequences should
be regarded as an extra hepatic manifestation of chronic hepatitis
C. Furthermore, these symptoms may already be present in
patients with mild chronic hepatitis C without clinical evidence
for cirrhosis. A previous report found a strong association
between reduced survival and sleep disorders in patients with
advanced liver disease [16]. The present cohort of patients with
relatively mild CHC is already followed for more than 3 decades
and so far there is apparently no indication to suspect a worse
prognosis despite the reported abnormal sleep pattern. Interest-
ingly, the abnormal sleep pattern was present in both the 12 vire-
mic patients as well as in those 7 patients who were HCV-RNA
negative by PCR. In this context it is worthwhile to mention a
recent report suggesting that primary and precursor forms of
liver speciﬁc microRNA (miR122) are regulated in a circadian
rhythm in the liver of animals [17]. In the detailed and well ref-
erenced discussion of this paper, the authors express their belief
that based on previous functional imaging studies, the described
symptoms in both HCV-RNA positive and negative patients are
the result of an encephalopathy, which is independent of the
state of viremia. However, the relatively small sample size and
the absence of functional imaging data for the speciﬁc study
cohort does not enable yet a ﬁrm conclusion regarding the role
of viremia in the above described symptoms.
Heeren and co-workers’ report is the result of an extensive
effort which is a case control study and descriptive by nature.
The investigators utilized a wide range of methods to reach
their conclusions but their results do not provide a clue regard-
ing the mechanism(s) involved in the sleep disturbance and its
consequences in CHC and this will remain a goal of future
research. Aberrant sleep patterns have previously been linked
to central nervous system involvement in persistent HCV infec-
tion affecting up to 65% of CHC patients [12,13,18]. It has been
suggested that sleep and the circadian system regulate a num-
ber of immune functions or vice versa [19,20]. For example,
the number of undifferentiated naïve T cells and production of
pro-inﬂammatory cytokines peak during early nocturnal sleep
while cytotoxic NK cells and anti-inﬂammatory cytokines peak
during day time [19]. The impact of past or present HCV infec-
tion on these parameters in the context of sleep disturbances is
still unknown. Sleep and the circadian timing systems are
driven by a complex interaction between multiple brain regions,
neurotransmitters and hormones. Moreover, up to 20 clock
genes and their protein products have been linked to control
of circadian rhythms through translational-transcriptional feed-
back loops [8,11]. However the interaction of the hepatitis C
virus with these genes and its impact on the molecular clock
is still unexplored except for a recent observation in vitro that
a circadian protein called PER2 interferes in viral replication
[21].
In summary, the discussed report provides descriptive evi-
dence that a history of past or present mild chronic hepatitis C
virus infection even without clinical evidence for cirrhosis or
‘‘traditional’’ hepatic encephalopathy is associated with an686 Journal of Hepatology 201altered sleep pattern, which has a negative impact on quality of
life and well being.
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